Bioventus

(NASDAQ) BVS

Current Price$8.48

Market Cap$578.57M

Since IPO (2021)-56%

5 Year-51%

1 Year+34%

1 Month-20%

Bioventus Financials at a Glance

Market Cap

$578.57M

Revenue (TTM)

$576.30M

Net Income (TTM)

$28.48M

EPS (TTM)

$0.41

P/E Ratio

20.72

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$8.48

Volume

Open

$8.70

Price

$8.48

Volume

Open

$8.70

Previous Close

$8.54

Daily Range

$8.39 - $8.81

52-Week Range

$5.81 - $11.25

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$8.48

Volume

Open

$8.70

Previous Close

$8.54

Daily Range

$8.39 - $8.81

52-Week Range

$5.81 - $11.25

Estimated Earnings Date

Aug 4, 2026

BVS News

doctor scientist microscope gloves mask (1)

BVS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioventus

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

930

CEO

Robert Claypoole, MBA

Website

www.bioventus.com

Headquarters

Durham, NC 27703, US

BVS Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

11%

Net Income Margin

Return on Equity

17%

Return on Capital

12%

Return on Assets

Earnings Yield

4.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$578.57M

Shares Outstanding

67.75M

Volume

Avg. Volume

561.11K

Financials (TTM)

Gross Profit

$382.43M

Operating Income

$58.55M

EBITDA

$99.21M

Operating Cash Flow

$73.98M

Capital Expenditure

-$2.56M

Free Cash Flow

$71.41M

Cash & ST Invst.

$51.24M

Total Debt

$311.35M

Bioventus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$132.09M

+6.6%

Gross Profit

$89.66M

+10.1%

Gross Margin

67.88%

N/A

Market Cap

$578.57M

N/A

Market Cap/Employee

$622.12K

N/A

Employees

930

N/A

Net Income

$3.11M

+218.1%

EBITDA

$20.05M

+25.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$35.85M

+57.2%

Total Debt

$272.08M

-21.3%

Accounts Receivable

$120.53M

+2.1%

Inventory

$83.19M

-11.5%

Long Term Debt

$253.33M

-17.9%

Short Term Debt

$18.75M

-49.8%

Return on Assets

4.38%

N/A

Return on Invested Capital

12.21%

N/A

Free Cash Flow

$8.36M

+141.5%

Operating Cash Flow

$8.93M

+146.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SRDXSurmodics, Inc.

SRDXSurmodics, Inc.$42.98+0.35%

CTKBCytek Biosciences, Inc.

CTKBCytek Biosciences, Inc.$3.98-2.69%

CBLLCeriBell, Inc.

CBLLCeriBell, Inc.$17.28-3.57%

KIDSOrthoPediatrics Corp.

KIDSOrthoPediatrics Corp.$18.17-1.94%

VREXVarex Imaging Corporation

VREXVarex Imaging Corporation$10.20-2.86%

LABStandard BioTools Inc.

LABStandard BioTools Inc.$0.81-2.60%

SMLRSemler Scientific, Inc.

SMLRSemler Scientific, Inc.$20.33-4.87%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

NOKNokia

NOKNokia$13.83-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.92-0.04%

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

SMRNuScale Power

SMRNuScale Power$10.34+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.03+0.03%

Questions About BVS

What is the current price of Bioventus?

Bioventus is trading at $8.54 per share.

What is the 52-week range for Bioventus?

Over the past 52 weeks, Bioventus has traded between $5.81 and $11.25.

How much debt does Bioventus have?

As of the most recent reporting period, Bioventus reported total debt of $288.42M.

How much cash does Bioventus have on hand?

Bioventus reported $35.85M in cash and cash equivalents in its most recent financial results.

What is Bioventus’s dividend yield?

Bioventus does not currently have a dividend yield.

Bioventus

Bioventus Financials at a Glance

BVS News

Why Shares of Bioventus Fell 14% on Wednesday

Why Bioventus Stock Is Sinking Today

Will a Powerful Acquisition Make This Early 2021 IPO a Buy?

BVS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bioventus

BVS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bioventus Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BVS

What is the current price of Bioventus?

What is the 52-week range for Bioventus?

How much debt does Bioventus have?

How much cash does Bioventus have on hand?

What is Bioventus’s dividend yield?

Premium Investing Services